Levormeloxifene

Levormeloxifene is a selective estrogen receptor modulator that was developed as an alternative to estrogen replacement therapy for the treatment and prevention of postmenopausal bone loss. The development was stopped because of a high incidence of gynaecologic adverse events during clinical trials.

References

* cite journal
author = Ravn P, Nielsen TF, Christiansen C.
year = 2006
month =
title = What can be learned from the levormeloxifene experience?
journal = Acta Obstet Gynecol Scand.
volume = 85
issue = 2
pages = 135–42
pmid = 16532904